ATE493997T1 - Zusammensetzung mit antifungaler wirksamkeit und deren verwendung - Google Patents

Zusammensetzung mit antifungaler wirksamkeit und deren verwendung

Info

Publication number
ATE493997T1
ATE493997T1 AT06123772T AT06123772T ATE493997T1 AT E493997 T1 ATE493997 T1 AT E493997T1 AT 06123772 T AT06123772 T AT 06123772T AT 06123772 T AT06123772 T AT 06123772T AT E493997 T1 ATE493997 T1 AT E493997T1
Authority
AT
Austria
Prior art keywords
composition
antifungal
antifungal effectiveness
preventive
benzoic acid
Prior art date
Application number
AT06123772T
Other languages
English (en)
Inventor
Susanne Herdis Vingerhoets-Jensen
Original Assignee
Happy Foot
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Happy Foot filed Critical Happy Foot
Application granted granted Critical
Publication of ATE493997T1 publication Critical patent/ATE493997T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Emergency Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT06123772T 2005-11-16 2006-11-09 Zusammensetzung mit antifungaler wirksamkeit und deren verwendung ATE493997T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL1030438A NL1030438C2 (nl) 2005-11-16 2005-11-16 Samenstelling met schimmelwerende eigenschappen, gebruik en werkwijze.

Publications (1)

Publication Number Publication Date
ATE493997T1 true ATE493997T1 (de) 2011-01-15

Family

ID=37635849

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06123772T ATE493997T1 (de) 2005-11-16 2006-11-09 Zusammensetzung mit antifungaler wirksamkeit und deren verwendung

Country Status (5)

Country Link
EP (1) EP1787652B1 (de)
AT (1) ATE493997T1 (de)
DE (1) DE602006019369D1 (de)
DK (1) DK1787652T3 (de)
NL (1) NL1030438C2 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011101825A1 (en) 2010-02-22 2011-08-25 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, clotrimazole and clobetasone, and a process to make it
WO2011101823A1 (en) 2010-02-22 2011-08-25 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating biopolymer, clotrimazole and dexamethasone, and a process to make it
WO2011101831A2 (en) 2010-02-22 2011-08-25 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid - clobetasone butyrate, and an antifungal agent -terbinafine hydrochloride and a process to make it
WO2011101827A2 (en) 2010-02-22 2011-08-25 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid - clobetasone butyrate, and an antifungal agent - miconazole nitrate, and a process to make it
WO2011101829A2 (en) 2010-02-22 2011-08-25 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid - betamethasone dipropionate and an antifungal agent - miconazole nitrate, and a process to make it
WO2011101824A1 (en) 2010-02-22 2011-08-25 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, miconazole, dexamethasone, and a process to make it
WO2011140309A2 (en) * 2010-05-05 2011-11-10 Biomor Israel Ltd. Combinations of antifungal compounds and tea tree oil
WO2012017372A1 (en) 2010-08-02 2012-02-09 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating, biopolymer, clobetasol propionate, miconazole nitrate and a process to make it
WO2012017381A1 (en) 2010-08-02 2012-02-09 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating, biopolymer, beclomethasone dipropionate, clotrimazole and a process to make it
WO2012017369A1 (en) 2010-08-02 2012-02-09 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating biopolymer, betamethasone dipropionate, clotrimazole and a process to make it
WO2012017370A1 (en) 2010-08-02 2012-02-09 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, betamethasone dipropionate, terbinafine hydrochloride and a process to make it
WO2012017383A1 (en) 2010-08-02 2012-02-09 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating biopolymer, beclomethasone dipropionate, terbinafine hydrochloride and a process to make it
WO2012017382A1 (en) 2010-08-02 2012-02-09 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating biopolymer, beclomethasone dipropionate, miconazole nitrate and a process make it
WO2012017371A1 (en) 2010-08-02 2012-02-09 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, clobetasole propionate, terbinafine hydrochloride and a process to make it
WO2012023079A1 (en) 2010-08-17 2012-02-23 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, fluticasone propionate, oxiconazole nitrate and a process to make it
WO2012023082A1 (en) 2010-08-17 2012-02-23 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid - hydrocortisone acetate, and an antifungal agent - terbinafine hydrochloride, and a process to make it
WO2012023077A1 (en) 2010-08-17 2012-02-23 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid - clobetasol propionate, and an antifungal agent - oxiconazole nitrate, and a process to make it
WO2012023080A1 (en) 2010-08-17 2012-02-23 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid - fluticasone propionate, and an antifungal agent -terbinafine hydrochloride and a process to make it
WO2012023078A1 (en) 2010-08-17 2012-02-23 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid - dexamethasone acetate, and an antifungal agent - oxiconazole nitrate, and a process to make it
WO2012023081A1 (en) 2010-08-17 2012-02-23 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid - hydrocortisone acetate, and an antifungal agent - oxiconazole nitrate, and a process to make it
WO2012049539A1 (en) 2010-10-15 2012-04-19 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate, a corticosteroid, and an antifungal agent, and incorporating a biopolymer, and a process to make it
MX2014005631A (es) * 2011-11-09 2014-10-17 Stockton Israel Ltd Combinaciones de compuestos antifungicos y aceite del arbol del te.
EP4008335A1 (de) * 2020-12-07 2022-06-08 Susanne Vingerhoets Jensen Zusammensetzung mit ätherischem melaleuca-alternifolia-öl, verwendung und verfahren
CN114288224B (zh) * 2022-01-26 2024-03-12 昆明悦馨生物科技有限公司 一种除螨、消毒组合物及其制备方法和用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5170486B2 (ja) * 1998-09-10 2013-03-27 バイオイコール ア−ゲー 局所適用性産物
RU2160585C1 (ru) * 1999-11-17 2000-12-20 Зао "Оргполимерсинтез" Состав для профилактики заболеваний полости рта
US20030017207A1 (en) * 2001-05-01 2003-01-23 Lin Shun Y. Compositions and methods for treating vulvovaginitis and vaginosis
US20040096569A1 (en) * 2002-11-15 2004-05-20 Barkalow David G. Edible film products and methods of making same
US20050271752A1 (en) * 2004-06-04 2005-12-08 Roth Ivar E Antifungal products and method of use

Also Published As

Publication number Publication date
NL1030438C2 (nl) 2007-05-21
DK1787652T3 (da) 2011-03-28
DE602006019369D1 (de) 2011-02-17
EP1787652A1 (de) 2007-05-23
EP1787652B1 (de) 2011-01-05

Similar Documents

Publication Publication Date Title
ATE493997T1 (de) Zusammensetzung mit antifungaler wirksamkeit und deren verwendung
WO2009032418A3 (en) Multilayer film having passive and active oxygen barrier layers
BRPI0717845A2 (pt) Uso de compostos, composições farmacêuticas e métodos para o tratamento e/ou profilaxia de enfermidades que podem ser tratadas com agentes de elevação de colesterol-hdl e compostos
WO2006127053A3 (en) Controlled release oral delivery systems
IL195030A (en) Dpp iv inhibitor formulations
CL2007002687A1 (es) Composicion pesticida en forma de gel o solido que contiene 0,001-50% en peso de al menos un compuesto pesticida efectivo contra artropodos, 0,5-20% en peso de al menos un polimero superabsorbente, 5-94,5% en peso de un material de relleno diferente
ATE491433T1 (de) Pflegemittel mit freisetzungspartikel
DE602008004841D1 (de) Blends von polyethylen und poly(hydroxycarbonsäure)
ATE529111T1 (de) Nützliche monobactam-antibiotika
WO2007106436A3 (en) Photoactive compounds and compositions and uses thereof
WO2009077693A3 (fr) Compositions comprenant au moins un derive de l'acide naphtoique, du peroxyde de benzoyle et au moins un agent filmogene
IL182655A (en) PATLONITRILL COMPOSITIONS
DE602005027415D1 (de) Sulfoalkylether-cyclodextrin-zusammensetzungen und herstellungsverfahren dafür
MX2010007498A (es) Composiciones fotoprotectoras contra radiacion ultravioleta visiblemente transparentes.
EP2181696A3 (de) Anti Pickel Hautbehandlungsmittel
BRPI1014067A8 (pt) Uso de pelo menos uma aziridina, composição, formulação de agente aglutinante, uso da composição, e materiais técnicos
NO20091517L (no) Emulsjon
EP1726632A4 (de) Abbauinhibitor
DE602006016127D1 (de) Zusammensetzung und dosierform mit einer festen oder halbfesten matrix
MX2008003422A (es) Composiciones que comprenden al menos un derivado de acido naftoico y al menos un compuesto de tipo polimero de poliuretano o derivados del mismo, procesos de preparacion y composiciones que comprenden al menos un derivado de acido naftoico y al meno
NO20044563D0 (no) Termoplaster
DE502006002341D1 (de) Holmiumdotierte anti-stokes-leuchtstoffe und sicherheitsmerkmale mit diesen leuchtstoffen
BRPI0914462A2 (pt) "composição tópica, método de prevenção ou redução da ocorrência de tratamento de acne e uso de uma composição"
BRPI0920351A2 (pt) composição farmacêutica para prevenção e tratamento de diabetes ou obesidade compreendendo um composto que inibe a atividade de dipeptidil peptidade-iv, e outros agentes antidiabéticos ou antiobesidade como ingredientes ativos
WO2009031148A3 (en) Adhesive formulations and multilayered assemblies

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties